<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CHOLINE MAGNESIUM TRISALICYLATE</span><br/>(cho'leen mag-ne'si-um tri-sal'i-ci-late)<br/><span class="topboxtradename">Trilisate<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">analgesic, salicylate</span>; <span class="classification">antipyretic</span><br/><b>Prototype: </b>Aspirin<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>500 mg, 750 mg, 1000 mg tablets; 500 mg/5 mL liquid</p>
<h1><a name="action">Actions</a></h1>
<p>Trilisate is a nonsteroidal, antiinflammatory preparation combining choline salicylate and magnesium salicylate. Mode of action
         is by inhibiting prostaglandin synthesis.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Trilisate has antiinflammatory, analgesic, and antipyretic action. Platelet aggregation is not affected.</p>
<h1><a name="uses">Uses</a></h1>
<p>Osteoarthritis, rheumatoid arthritis, and other arthrides. Preferable to aspirin for patients with GI bleeding.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to nonacetylated salicylates; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Chronic renal and hepatic failure, peptic ulcer; patients on coumadin or heparin; lactation; older adults.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Arthritis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1.52.5 g/d in 13 divided doses (max: 4.5 g/d)<br/><br/><span class="indicationtitle">Mild to Moderate Pain, Fever</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 23 g/d in 2 divided doses<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 3060 mg/kg/d in 34 divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with food to reduce gastric upset. Do not give with antacids.</li>
<li>Store at 59°86° F (15°30° C).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">GI:</span> Vomiting, diarrhea. <span class="typehead">CNS:</span> Headache, vertigo, confusion, drowsiness. <span class="typehead">Special Senses:</span> Tinnitus. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Aminosalicylic acid</b> increases risk of salicylate toxicity; <b>ammonium chloride</b> and other <b>acidifying agents</b> decrease its renal elimination, increasing risk of salicylate toxicity; <span class="classification">anticoagulants</span> increase risk of bleeding; <span class="classification">carbonic anhydrase inhibitors</span> enhance salicylate toxicity; <span class="classification">corticosteroids</span> compound ulcerogenic effects; increases <b>methotrexate</b> toxicity; low doses of salicylates may antagonize uricosuric effects of <b>probenecid,</b>
<b>sulfinpyrazone.</b>
<h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from small intestine. <span class="typehead">Onset:</span> 30 min. <span class="typehead">Peak:</span> 13 h. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 23 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>As with other <small>NSAID</small>s, the antipyretic and antiinflammatory effects may mask usual S&amp;S of infection or other diseases.
         </li>
<li>Assess for GI discomfort; nausea, gastric irritation, indigestion, diarrhea, and constipation are frequent complaints.</li>
<li>Monitor for S&amp;S of bleeding. Closely monitor PT if used concurrently with warfarin.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Avoid taking aspirin, <small>NSAID</small>s, or acetaminophen concurrently with drug.
         </li>
<li>Avoid dangerous activities until reaction to drug is determined, due to possible CNS effects (e.g., vertigo, drowsiness).</li>
<li>Report tinnitus or persistent gastric irritation and epigastric pain.</li>
<li>Report any unexplained bruising or bleeding to physician.</li>
<li>Hypoglycemic effects may be enhanced for those with type 2 diabetes taking an oral hypoglycemic agent (OHA).</li>
<li>Do not give to children or teenagers with chickenpox, influenza, or flu symptoms because of association with Reye's syndrome.</li>
<li>Do not breast feed without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>